'Foot ulceration' presentation slideshows

Modification of Footwear to Prevent Ulcerations

Modification of Footwear to Prevent Ulcerations. Speaker : Alison Deacon, Podiatrist B.Sc. ( Hons ) MChS HPC Optimum Health Services Ltd (UK). FACTS & FIGURES. In the developed world 5% of people with diabetes have ulcers and use 12-15% of healthcare resources

650 views • 54 slides

422 views • 42 slides

Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain (DPN)

Duloxetine in the Treatment of Diabetic Peripheral Neuropathic Pain (DPN). Contents. Introduction Mechanism of Action Efficacy in DPNP Pharmacokinetics, Safety and Tolerability Conclusion. Definition of diabetic neuropathy.

2.49k views • 41 slides

FOOTCARE AND DIABETES

FOOTCARE AND DIABETES. James R. Christina, DPM Director Scientific Affairs American Podiatric Medical Association. Epidemiology of Diabetes. 23.6 million in US 7.8% of population ~ 10% in District of Columbia 8.7% of those > 20 yrs old 24% of Hispanic Americans 3,651 diagnosed daily

412 views • 31 slides

Biomechanics of the Diabetic Foot

Biomechanics of the Diabetic Foot. Robert G. Frykberg, DPM, MPH Chief, Podiatry Section Carl T. Hayden VA Medical Center Phoenix, AZ USA. Diabetes Mellitus. Trauma. Neuropathy. Vascular Disease. MOTOR SENSORY AUTONOMIC MICROVASCULAR MACROVASCULAR

1.29k views • 28 slides

Diabetic foot

Diabetic foot. ms hosseini , Clinical Research Development center, Baqiatallah University of Medical Sciences. Agenda. Introduction Pathway to Ulceration Risk classification Evaluation of diabetic foot Guideline Recommendations. Introduction.

802 views • 27 slides

MODERATE Risk

MODERATE Risk. 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors. x6 more likely to ulcerate. Annual assessment by health care professional Agree individual management/treatment plan

223 views • 20 slides

A Summary of Guidelines for Managing the Diabetic Foot

291 views • 19 slides

Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance

709 views • 17 slides

Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance

378 views • 17 slides

Aim

Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers. Mohammad Reza Mohajeri-Tehrani, MD; Faezeh Nasiripoor, MSc; Giti Torkaman, PhD; Mehdi Hedayati, PhD; Zohreh Annabestani, MD; Mohammad Reza Asadi, MSc. Aim

184 views • 5 slides

Aim

Effect of low-intensity direct current on expression of vascular endothelial growth factor and nitric oxide in diabetic foot ulcers. Mohammad Reza Mohajeri-Tehrani, MD; Faezeh Nasiripoor, MSc; Giti Torkaman, PhD; Mehdi Hedayati, PhD; Zohreh Annabestani, MD; Mohammad Reza Asadi, MSc. Aim

54 views • 5 slides

3 Methods

140 views • 1 slides

Figure 3

B) ROC curve of probability for foot ulceration. A) Best Cox regression model of foot ulceration. Figure 3.

100 views • 1 slides